Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • agwe
    Junior Member
    • Oct 2010
    • 6

    #1

    Cuffdiff q-values

    I am having problem understanding the Cuffdiff q-values. I am using Cufdiff v.2.1.1 and I understand that in this version the lowest possible p-value one would see is 5e-05. For my analysis, with 2 conditions and 10 biological replicates each, I am using a GTF file with ~29,000 genes and ~205,000 transcripts.

    As a result I can see that e.g. 300 isoforms in the isoform_exp.diff file have a p-value of 5e-05, but because of the multiple testing correction the q-values for those isoforms are all equal to 0.0504822, so not significant... When I look at the actual values of the replicates FPKMs, they look like truly differentially expressed. It seems that with my setup, using a GTF file with so many possible transcripts, I will never arrive at anything statistically significant with Cuffdiff...

    Similarly, in case of differential gene expression, I have two such experiments, both using the same Cuffmerge generated GTF file, I see:
    1) 199 significant genes, while only 136 of them have p-value of 5e-05
    2) no significant genes, while 12 genes have p-values of 5e-05

    In both experiments I am looking at the same number of genes, shouldn't then the 12 genes from experiment 2) be marked as significant?

    Does anyone see similar behavior?
  • TiborNagy
    Senior Member
    • Mar 2010
    • 329

    #2
    If you use a statistical test many times, you would get significant results by chance. To reduce the number of false positives come from this phenomenon, multiple test correction was used. So you always get equal or smaller number of significant results after multiple test correction.

    Comment

    • agwe
      Junior Member
      • Oct 2010
      • 6

      #3
      I understand the principle behind multiple testing correction. What I don't understand is why in my results I get 12 genes with p-value of 5e-5, which is the lowest value one can see in Cufflinks, yet those are not significant after correction...

      And as the multiple testing correction q-value depends on the number of tests run, or in other words genes/transcripts tested, if I test 200,000 transcripts I will never get a significant p-value in this setup.

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        The multiple testing q-value will depend on the distribution of p-values, not just their number. At least that's the case with the method that's likely being used (Benjamini-Hochberg). It's the incorporation of their distribution (in the null case, we expect p-values to be uniformly distributed, so we can use that expectation to adjust things) that allows you to have significant adjusted p-values even after 10s or 100s of thousands of tests, even with a minimum p-value of 5e-5 (though this doesn't help things).
        Last edited by dpryan; 04-01-2014, 08:22 AM.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 07:41 AM
        0 responses
        12 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        39 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Working...